Global Bio Absorbable Implants Market Overview:
Bioabsorbable implants are degraded in a biological environment, and their breakdown products are incorporated into normal cellular physiologic and biochemical processes. These implants are used in orthopedic surgical procedures, spinal reconstruction surgeries. These materials are utilized for the fixation of fractures as well as for soft-tissue fixation. These implants offer the advantages of gradual load transfer to the healing tissue, reduced need for hardware removal, and radiolucency, which facilitates postoperative radiographic evaluation.
Growth Drivers
- Increasing geriatric population suffering from bone fractures
- Technological advancement
- An increasing number of sports-related injuries and road accidents are increasing the number of trauma cases
- Growing cases of chronic diseases and the increasing geriatric population
Roadblocks
- High cost of bioabsorbable implants and surgery
- Time-consuming
Opportunities
- Increased in the usage of bioabsorbable implants as alternatives to conventional synthetic implants
Challenges
- The exceptionally high corrosion rate in the physiological environment
Competitive Landscape:
Companies in the market are concentrating on the healthcare industry. North America is the dominant share, factors such as the high prevalence of cardiovascular disease and increase in the geriatric population. Rapidly improving healthcare infrastructure and the presence of a broad base of the target population has been growing fastest in the Asia Pacific region. Key players in the market are focused on adopting merger and acquisition strategies to enhance their product portfolio.
Some of the key players profiled in the report are Meryl Life Sciences Pvt. Ltd. (India), Medtronic Plc. (Irland), Smith & Nephew Plc. (United Kingdom), Stryker Corporation (United States), Wright Medical Group (United States), Syntellix AG (United States), Q3 Medical Devices Limited (Irland), Bioretec Ltd (Finland), CONMED Corporation (United States), Depuy Synthes (United States) and Zimmer Biomet Holdings, Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Bio Absorbable Implants market by 2026. Considering Market by Material , the sub-segment i.e. Metallic will boost the Bio Absorbable Implants market. Considering Market by End-Use Industries , the sub-segment i.e. Hospitals will boost the Bio Absorbable Implants market.
Sep 30, 2021: Medtronic plc. announced to expand the minimally invasive spine surgery ecosystem. This ecosystem is helping surgeons remove variability in the surgical procedure, streamline and personalize care, and enable better patient outcomes. and Nov 11, 2020: Stryker announced acquisition with Wright Medical Group N.V. This acquisition enhances global market position in trauma and extremities, providing significant opportunities to advance innovation.
What Can be Explored with the Bio Absorbable Implants Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Bio Absorbable Implants Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Bio Absorbable Implants
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Bio Absorbable Implants market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Bio Absorbable Implants market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Healthcare Industry/Centres, Research & Development, Hospitals, Manufacturers and Emerging Companies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.